Cultrex Basement Membrane Extract, Type 3, Pathclear
Key Product Details
Features: | Cultrex Basement Membrane Extract (BME), Type 3 is an extracellular matrix hydrogel that is qualified specifically for use in in vivo xenograft and tumorgraft models. |
Key Benefits: |
|
Order Information
Shipping Information
$35 to United States
Products in stock will be shipped in 1-3 business days unless specified.
Assay Procedure
Citations for Cultrex Basement Membrane Extract, Type 3, Pathclear (5)
Citations are publications that use Bio-Techne products. Selected citations for Cultrex Basement Membrane Extract, Type 3, Pathclear include:
-
Species: Mouse
Sample Types: In Vivo
Applications: BioassayR Yang et al. (2021), Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy Nature Communications, 12(1):832.
PMID: 33547304 -
Species: Xenograft
Sample Types: In Vivo
Applications: In VivoCM Yamazaki et al. (2021), Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance Nature Communications, 12(1):3528.
PMID: 34112795 -
Species: Mouse
Sample Types: In Vivo
Applications: In VivoL Yin et al. (2021), Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer Oncogene, 0(0).
PMID: 34799660 -
J Cheng et al. (2020), GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein J. Clin. Invest., 130(2):1036-1051.
PMID: 31961340 -
Doci C et al. (0), Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma. Cancer Re75(14):2937-48.
PMID: 25952650
There are no citations that match your criteria.